Sign in
CELZ Stock Price, Chart, Stats & News
Creative Medical Technology Holdings, Inc.
Save
Creative Medical Technology Holdings, Inc. (CELZ) does not currently pay a dividend.
1.91M
Market cap
–
Current P/E
–
Forward P/E
CELZ chart
Fundamentals
Gross margin | 63.43% |
Operating margin | -100324.78% |
Pretax margin | -99916.80% |
Net margin | -99916.80% |
Effective tax rate | – |
ROA | -76.77% |
ROE | -85.66% |
D/E | – |
Interest coverage ratio | – |
CELZ valuation
P/E | – |
P/S | 847.32x |
P/B | 0.62x |
P/CF | -0.80x |
P/FCF | -0.87x |
P/OCF | -0.80x |
PEG | -0.06x |
EV multiple | -2.04x |
About
Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.
Similar securities
Based on sector and market capitalization
Report issue